Aldesleukin

CAS 110942-02-4 1 current recordProtein

Who holds supplier records for Aldesleukin? 1 organisation holds a current record for Aldesleukin: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: France (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 11 Nov 2026. How we read these records

Cite as: PharmaTek, “Aldesleukin: DMF and CEP holder records”, record as of 11 Nov 2026, pharmatek.co.uk/directory/api/aldesleukin

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Aldesleukin. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • ILTOO PHARMA
    Active DMF 33929 · latest filing Jun 2019
    France
Need Aldesleukin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Aldesleukin is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1201438).

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Lymphocyte Growth Factor
Physiologic effect
Increased Lymphocyte Activation; Increased Lymphocyte Cell Production
Chemical structure
Interleukin-2

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Aldesleukin?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Aldesleukin: ILTOO PHARMA (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Aldesleukin Drug Master Files are active?

ILTOO PHARMA (DMF 33929). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Aldesleukin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Aldesleukin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.